Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL6701329

CC(C)CNc1ccc([N+](=O)[O-])cc1.N

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.62
ALDH1A1 P00352 6/20 0.53
RECQL P46063 1/20 0.53
HSD17B10 Q99714 1/20 0.53
SMN1; SMN2 Q16637 4/20 0.52
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
HTT P42858 2/20 0.52
HPGD P15428 2/20 0.52
ALOX12 P18054 2/20 0.51
RAB9A P51151 2/20 0.51
RIPK1 Q13546 1/20 0.49
GLA P06280 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
LMNA P02545 1/20 0.49
MAPK1 P28482 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
PTPRF P10586 1/20 0.47
PTPN2 P17706 1/20 0.47
PTPN1 P18031 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8635097 0.98 MAPT (0.65) MAPTALDH1A1RECQLHSD17B10SMN1; SMN2
SCHEMBL9820267 0.84 MAPT (0.61) MAPTALDH1A1RECQLHSD17B10SMN1; SMN2
SCHEMBL30800484 0.84 MAPT (0.61) MAPTALDH1A1RECQLHSD17B10SMN1; SMN2
SCHEMBL6563884 0.84 MAPT (0.61) MAPTALDH1A1RECQLHSD17B10SMN1; SMN2
SCHEMBL4616467 0.83 MAPT (0.59) MAPTALDH1A1RECQLHSD17B10SMN1; SMN2
SCHEMBL11214950 0.81 MAPT (0.57) MAPTALDH1A1RECQLHSD17B10SMN1; SMN2
SCHEMBL8292078 0.80 MAPT (0.58) MAPTALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL3662904 0.80 MAPT (0.59) MAPTALDH1A1RECQLHSD17B10SMN1; SMN2
SCHEMBL5157176 0.80 MAPT (0.59) MAPTALDH1A1RECQLHSD17B10SMN1; SMN2
SCHEMBL9149907 0.79 ALDH1A1 (0.63) MAPTALDH1A1RECQLHSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040180925-A1 Dipeptidylpeptidase-IV inhibitor KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-09-16 US disclosed
EP-1354882-A1 DIPEPTIDYL PEPTIDASE IV INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-10-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040180925-A1 Dipeptidylpeptidase-IV inhibitor DPP4, DPP3, DPP9 MAPT 3376/4885ALDH1A1 925/4885RECQL 4374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.